JAGUAR HEALTH, INC. Prepaid Expense and Other Assets, Current
JAGUAR HEALTH, INC. (JAGX) had Prepaid Expense and Other Assets, Current of $3.43 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-19
- 2026-06-30: Prepaid Expense and Other Assets, Current $3.43M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $2.05M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $2.22M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $13.74M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.43M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $2.05M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $2.22M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $13.74M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $13.66M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $12.80M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $12.20M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $12.39M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $13.14M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $11.31M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $10.12M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.61M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $9.78M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.87M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.36M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.59M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.53M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $3.88M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $4.34M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $4.91M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $4.81M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $3.11M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.36M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $2.50M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.09M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.07M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $1.26M 10-K · filed 2021-03-31 | $1.26M 10-K · filed 2020-04-03 |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $822.80K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $866.17K 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $1.24M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $1.77M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $966.08K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $365.33K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $497.37K 10-K · filed 2019-04-10 | |
| 2017-09-30 | $609.51K 10-Q · filed 2017-11-20 | |
| 2016-12-31 | $302.69K 10-K · filed 2018-04-09 | |
| 2016-09-30 | $655.21K 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $324.08K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |